US 9198983
Compositions and methods for inhibiting expression of Mylip/Idol gene
granted A61KA61K48/005
Quick answer
US patent 9198983 (Compositions and methods for inhibiting expression of Mylip/Idol gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K48/005